Bela Patel, M.D.

NPI 1750309076ActiveIndividual· Internal Medicine, Pulmonary Disease· Houston, TX

Internal Medicine, Pulmonary Disease (M.D.) in Houston, Texas, trained at University of Texas Medical School at Houston (class of 1993). Their prescriptions cost Medicare Part D more than their services did: $2,898,620 for 597 claims, against $6,910 paid for services in 2024. Merck Sharp & Dohme LLC reported $24.73 in payments in 2025, mostly food and beverage.

Overview

NPI	1750309076
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jul 17, 2006
Last updated in NPPES	Feb 9, 2024
Certified by provider	Feb 9, 2024

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	J6647	TX
Internal Medicine	207R00000X	J6647	TX
Internal Medicine, Critical Care Medicine	207RC0200X	J6647	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Critical Care (Intensivists) (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	35
Services billed	89 across 12 procedure codes
Paid by Medicare	$6,910

Part D prescriptions in 2024

Prescriptions (claims)	597 · 821 30-day fills
Patients	57
Total drug cost	$2,898,620
Generic share	63% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Medical School at Houston
Graduation year	1993
Medicare specialty	Critical Care (Intensivists)
Telehealth	Offers telehealth